
Yuxuan Hu
Articles
-
Jan 11, 2025 |
arxiv.org | Yuxuan Hu
arXiv:2501.06649 (math) View PDF Comments: Subjects: Algebraic Geometry (math.AG); Algebraic Topology (math.AT); Category Theory (math.CT) Report number: CPH-GEOTOP-DNRF151 Cite as: arXiv:2501.06649 [math.AG] (or arXiv:2501.06649v1 [math.AG] for this version) https://doi.org/10.48550/arXiv.2501.06649 Submission history From: Yuxuan Hu [ view email] [v1] Sat, 11 Jan 2025 22:06:57 UTC (529 KB) Bibliographic Tools Bibliographic Explorer Toggle Bibliographic Explorer () Connected Papers Toggle...
-
Apr 11, 2024 |
pubs.acs.org | Xin Wei |Cheng Xu |Penghui Cheng |Yuxuan Hu
Download Hi-Res ImageDownload to MS-PowerPointCite This:J. Am. Chem. Soc. 2024, XXXX, XXX Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses).
-
Mar 6, 2024 |
onlinelibrary.wiley.com | Cheng Xu |Mengke Xu |Yuxuan Hu |Jing Liu
Although colorectal cancer diagnosed at early stage shows high curability, methods simultaneously possessing point-of-care testing ability and high sensitivity are limited. Here, we present an orally deliverable biomarker-activatable probe (termed as HATS) for early detection of orthotopic tumor via remote urinalysis.
-
Feb 27, 2024 |
mdpi.com | Jiayu Song |Yuxuan Hu |Lei Zhu |Chengyuan Zhang
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →